Stock Market Today, March: CytomX Surges on Positive Data
CytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Learn Which Robo Advisor Is Easiest For Beginners by comparing onboarding, automation, and educational tools designed for first‑time investors.
19,697 articlesCytomX Therapeutics delivered a sharp rally after promising Phase 1 data for its colorectal cancer program. This arti...
Swell has halted its Swellchain on the Optimism Superchain, leaving users scrambling to recover assets as the latest ...
The Federal Reserve is expected to hold rates steady this week, a move that policymakers say could stabilize markets ...
Entrepreneurship powered America’s rise, and Steve Case argues we must expand that engine nationwide to guard the cou...
XRP has faced big swings, yet Ripple’s developments could shift the long-term outlook. This guide maps out scenarios ...
SVOL offers a sizzling income stream, but the hidden tail risks tied to volatility bets are real. This piece weighs c...
A bloc of 16 attorneys general filed a federal lawsuit against HUD, saying guidance to FHAP agencies could decertify ...
May home sales fell again, highlighting an ongoing affordability squeeze as mortgage costs remain elevated. The data ...
Lucid has fallen sharply, dropping more than half in the last year. This article breaks down why the stock’s slump ha...
Nokia’s latest move isn't about handsets—it's about AI-friendly data-center networks. The Nokia acquired Infinera qui...
Analysts map a long-range path for SoFi Technologies, with a potential move into the upper 40s by 2030 as digital ban...
Today's market action centers on semiconductor chatter, a solid Micron after-hours surge, and a mixed read across maj...